share_log

Morgan Stanley Downgrades Treace Medical Concepts to Equal-Weight, Lowers Price Target to $5.5

Benzinga ·  May 8, 2024 11:47

Morgan Stanley analyst Drew Ranieri downgrades Treace Medical Concepts (NASDAQ:TMCI) from Overweight to Equal-Weight and lowers the price target from $15 to $5.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment